Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INFINI RESOURCES LIMITED Director's Dealing 2024

Jan 29, 2024

65087_rns_2024-01-29_49baa4f5-36fb-490e-a92b-4bae445e54e0.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3X Initial Director’s Interest Notice

Rule 3.19A.1

Appendix 3X

Initial Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity Infini Resources Limited ABN 77 656 098 583

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Dr Andrew (Andy) Wilde
Date of appointment 29 January 2024

Part 1 - Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

Nil

  • See chapter 19 for defined terms.

11/3/2002

Appendix 3X Page 1

Appendix 3X Initial Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of Number & class of Securities interest Note: Provide details of the circumstances giving rise to the relevant interest. Nil

Part 3 – Director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Director appointment letter
Nature of interest The Company has agreed, subject to ASX and
Shareholder approvals, to issue Dr Wilde 500,000
unlisted incentive options exercisable at $0.35
each on or before 12 January 2027 (includes
500,000 options subject to escrow provision until
15 January 2026).
Name of registered holder
(if issued securities)
N/A
No. and class of securities to which
interest relates
500,000 unlisted escrowed options (exe $0.35;
exp 12/01/27).
  • See chapter 19 for defined terms.

Appendix 3X Page 2

11/3/2002